Introduction {#s01}
============

Microglia, the resident macrophages of the central nervous system (CNS), form a continuous cellular network throughout the CNS that controls brain immune and inflammatory responses and contributes to the regulation of neuronal homeostasis ([@bib42]). Recent studies have revealed that the brain microenvironment is heterogeneous throughout the various brain regions, and that differences in neuronal subtypes, metabolism, and function could influence or be influenced by the microglia that reside in these regions ([@bib23]; [@bib69]; [@bib4]), hence the need to study microglia in their regional context.

The cerebellum is an ancient part of the CNS known to control motor coordination and function ([@bib46]), and is increasingly appreciated as an important regulator of higher cognitive functions ([@bib73]). However, most studies on neuronal--microglial interactions have focused on the forebrain ([@bib55]; [@bib63]; [@bib61]), and very little is known about the regulation of the microglial network in the cerebellum, prompting us in this study to probe the mechanisms that regulate microglia homeostasis in the cerebellum.

Signaling through the CSF-1 receptor (CSF-1R) is required for microglia homeostasis ([@bib64]), as suggested by the profound microglia depletion observed in *Csf1r*-deficient mice ([@bib13]; [@bib21]), but surprisingly, mice that lack the main CSF-1R ligand, CSF-1 ([@bib78]; [@bib21]), show only a moderate reduction of microglia ([@bib77]). This discrepancy was explained in subsequent reports by the identification of an alternate CSF-1R ligand named IL-34 ([@bib44]), which is produced by CNS populations in the forebrain and shown to control microglial maintenance in the forebrain, but not in the cerebellum ([@bib24]; [@bib64]). These results prompted us to revisit the distribution of CSF-1R ligands in the cerebellum and their contribution to cerebellar microglial maintenance.

Using a mouse model in which CSF-1 was specifically depleted from Nestin (Nes)^+^ cells, along with extensive profiling of microglia in different brain regions of the mouse and human brain, we found that the CSF-1R ligand, CSF-1, shaped cerebellar microglia identity and was uniquely required for microglial homeostasis in the cerebellum. Strikingly, disruption of cerebellar microglia in CSF-1--deficient brains was associated with profound alterations of Purkinje cell (PC) morphology and function, and with motor learning and social interaction defects.

Results {#s02}
=======

IL-34 and CSF-1 have nonoverlapping distribution in the forebrain and cerebellum, where they shape microglia numbers and phenotype {#s03}
----------------------------------------------------------------------------------------------------------------------------------

NextGen sequencing of microglia isolated from different human brain regions revealed that human cerebellar microglia expressed a transcriptional program distinct from that of forebrain microglia (Table S1 and [Fig. 1, A and B](#fig1){ref-type="fig"}), and were particularly enriched in metabolism and energy genes (*COX7B, ATP5A1,* and *PSMD9*), a conserved functional network previously described in mouse cerebellar microglia ([@bib23]; [@bib4]). Many orthologous genes more highly expressed in human cerebellar compared with forebrain microglia were also more highly expressed in mouse cerebellar microglia (*NUPR1, EMP3, CDR1, LGALS3,* and *APOE*; [Fig. 1 B](#fig1){ref-type="fig"}), suggesting that similar tissue factors might imprint the cerebellar microglial program in human and mouse brains.

![**Cerebellar microglia depend on CSF-1 growth factor for their maintenance in tissue. (A)** Volcano plot showing select DEGs between human cerebellar and forebrain (superior temporal gyrus) microglia. *n* = 2 matched patient samples/brain region. **(B)** Heat map and representative genes of adult human and mouse orthologous genes with conserved fold change in cerebellar and forebrain cortical microglia. **(C)** Representative images from single-molecule RNA in situ hybridization for *Il34*, *Csf1*, and *Csf1r* in WT P8 cerebral cortex, hippocampus, and cerebellum. I--VI, cortical layers; CA, cornu ammonis; DG, dentate gyrus; EGL, external granular layer; IGL, internal granular layer; WM, white matter. Scale bars, 100 µm. **(D--F)** Representative flow-cytometric plot (D) and quantification of the percent of live (E) and absolute (abs) count (F) of forebrain and cerebellar microglia (defined as doublet^−^DAPI^−^CD11b^+^CD45^int^). *n* = 3--7 adult mice/group. Data are pooled from five independent experiments. ns, not significant. **(G)** Representative confocal images of Iba1 (cyan) immunofluorescence stainings. Images representative of *n* = 3 adult mice/group. Scale bar, 20 µm. **(H)** Quantification of Iba1^+^ microglia/field in cortex and cerebellum. *n* = 3 adult mice/group, *n* = 3 or 4 fields/region/mouse. Data are a representative of two independent experiments. DEGs in A defined as Benjamini--Hochberg adjusted P-value \< 0.1. Conserved genes in B defined as one to one orthologues expressing \>5 TPM in all replicates of at least one brain region in both species, and having an unadjusted P-value \< 0.05 and a log~2~FC \> 0.5 in the same direction in both species (log~2~FC \> 0.75 in the same direction for listed genes). Graphs show mean ± SEM. \*, P ≤ 0.05; \*\*, P ≤ 0.01; \*\*\*, P ≤ 0.001; \*\*\*\*, P \< 0.0001 using multiple Student's *t* tests (E and F) or ANOVA with Tukey's post hoc test (H).](JEM_20182037_Fig1){#fig1}

Although IL-34 and CSF-1 signal through the same CSF-1R and can both promote macrophage survival, they have distinct distributions in the brain ([@bib64]). Using RNA in situ hybridization ([Fig. 1 C](#fig1){ref-type="fig"}) and cell type--specific translating ribosome affinity purification (TRAP; Fig. S1 A), we found that *Il34* expression dominated in forebrain regions, such as the cerebral cortex and the CA3 region of the hippocampus, while *Csf1* was most strongly expressed in the cerebellum ([Fig. 1 C](#fig1){ref-type="fig"}). The cellular source of *Il34* and *Csf1* also differed, as glial cells highly expressed *Csf1,* while *Il34* was mainly produced by neurons (Fig. S1 A). *Csf1r* expression, however, was prominent in microglia throughout the brain ([Fig. 1 C](#fig1){ref-type="fig"}). As in mouse brains, human forebrain regions mainly expressed *IL34*, whereas *CSF1* predominated in the cerebellum (Fig. S1 B).

Given the distinct spatial distribution of *Csf1* and *Il34* in the brain parenchyma, we tested how the specific depletion of each ligand affected microglia in different brain regions. Because *Csf1^op/op^* mice, which bear a spontaneous CSF-1 null mutation, have bone and musculoskeletal developmental defects that may indirectly affect brain development ([@bib78]), we crossed *Nes^Cre/+^* mice to *Csf1^fl/fl^* mice (*Nes^Cre^Csf1^fl/fl^*) and significantly reduced *Csf1* specifically in the cerebellum, while *Il34* expression remained unaffected (Fig. S1 C). In the brain, Nes^+^ cells mostly consist of CD45^−^ cells, including neuronal and glial progenitor cells, but not microglial cells (Fig. S1 D). Generation of *Nes^Cre^Csf1^fl/fl^* mice allowed for *Csf1* depletion from all cell types deriving from neuroectodermal stem cells, including astrocytes, one of the main sources of *Csf1* (Fig. S1 A), as well as oligodendrocytes, and neurons, thus circumventing the development defects observed in *Csf1^op/op^* mice.

In contrast to *Il34^LacZ/LacZ^*-deficient mice, which have reduced microglia in forebrain regions, including the cerebral cortex and hippocampus ([@bib24]; [@bib75]), *Nes^Cre^Csf1^fl/fl^* mice had normal forebrain microglia frequencies and numbers, but significantly reduced microglia in the cerebellum ([Fig. 1, D--H](#fig1){ref-type="fig"}), thus mirroring the expression pattern of *Il34* and *Csf1* in their respective brain regions. Importantly, CSF-1 depletion from microglia in *Cx3cr1^Cre^Csf1^fl/fl^* mice had no defects in the cerebellar microglial compartment (Fig. S1, E and F), establishing that a microglial CSF-1 source is not required for microglial homeostasis in the cerebellum, and excluding a relevant impact of transient *Cx3cr1* expression during neuronal development ([@bib25]) in *Cx3cr1^Cre^Csf1^fl/fl^* mice. We also generated knockout mice that lacked both CSF-1 and IL-34 (*Nes^Cre^Csf1^fl/fl^Il34^Lacz/Lacz^*) and found almost a complete depletion of microglia within all regions of the brain ([Fig. 1, D--H](#fig1){ref-type="fig"}), establishing the critical and nonredundant roles for CSF-1 and IL-34 in microglial homeostasis, as well as the significant contribution of CSF-1 to the maintenance of cerebellar microglia.

Disruption of CSF-1--CSF-1R signaling predominantly affects cerebellum homeostasis {#s04}
----------------------------------------------------------------------------------

NextGen profiling of the few cerebellar microglia that persisted in *Nes^Cre^Csf1^fl/fl^* mice at postnatal day 8 (P8), the peak of cerebellar foliation and lengthening of cerebellar folia ([@bib67]; [Fig. 2 A](#fig2){ref-type="fig"} and Fig. S2, A--C) revealed a significantly altered transcriptional program (Table S2 and [Fig. 2, A--C](#fig2){ref-type="fig"}), including down-regulation of homeostatic and sensome genes (*Mertk*, *Gpr34*, and *P2ry12*; [@bib47]), growth and development genes (*Egr2, Spp1,* and *Cd9*), and metabolism genes (*Hif1a* and *Slc37a2*; [Fig. 2, A and C](#fig2){ref-type="fig"}). Many down-regulated genes (*Apoe*, *Lpl*, *Spp1*, *Itgax*, *Gpnmb*, and *Clec7a*) are also known to be developmentally regulated in microglia ([@bib47]). There was also a striking up-regulation of immune response genes (*Axl*, *Lamp1*, and *Clec4a1*; [Fig. 2, A--C](#fig2){ref-type="fig"}). Down-regulation of growth, development, and metabolism genes (*Klf2*, *Notch1*, *Tgf1*, *Dagla*, *Dotl1*, and *Capn2*) also persisted in adult CSF-1--deficient mice ([Fig. 2 D](#fig2){ref-type="fig"}). In contrast, adult forebrain microglia in IL-34--deficient mice acquired a gene signature found in aging and neurodegenerative diseases, also known as a disease-associated microglial (DAM) signature ([@bib36]; [Fig. 2 D](#fig2){ref-type="fig"}). The DAM signature was more prevalent in adult IL-34--deficient brain compared with adult CSF-1--deficient brain ([Fig. 2 E](#fig2){ref-type="fig"}), consistent with prior reports that human Alzheimer's postmortem brains have reduced IL-34 levels particularly in the forebrain, and not the cerebellum ([@bib74]). Accordingly, we found that ex vivo exposure of neonatal microglia ([Fig. 2 F](#fig2){ref-type="fig"}) to CSF-1 or IL-34 drives a common transcriptional program, whether the microglia were isolated from the cerebellum or forebrain (Table S3, Fig. S2 D, and [Fig. 2 G](#fig2){ref-type="fig"}), particularly with CSF-1 inducing development and metabolism genes (*Klf2*, *Nes*, and *Jag1*) and IL-34 inducing immune genes (*Clec4a2*, *Cd86*, and *Tnfrsf1b*; [Fig. 2 G](#fig2){ref-type="fig"}), indicating that IL-34 and CSF-1 are among the key drivers of regional microglial transcriptional profiles.

![**CSF-1 and IL-34 drive distinct microglial programs in the brain tissue. (A)** Hierarchical clustering (left) and select representative genes (right) from 860 DEGs between P8 *Csf1^fl/fl^* and *Nes^Cre^Csf1^fl/fl^* cerebellar microglia. **(B)** Normalized expression (RPKM) of select immune response and homeostatic and metabolism genes in *Csf1^fl/fl^* and *Nes^Cre^Csf1^fl/fl^* cerebellar microglia. *n* = 3 mice/group. **(C)** GSEA analysis of P8 *Nes^Cre^Csf1^fl/fl^* cerebellar microglia showing positive enrichment of genes involved in immune response pathways, and negative enrichment of genes involved in developmental and metabolic pathways. **(D)** Volcano plots showing select development, metabolism, and DAM genes in adult *Nes^Cre^Csf1^fl/fl^* cerebellar microglia (left) and select homeostatic and DAM genes in adult *Il34^Lacz/Lacz^* forebrain microglia (right). **(E)** Quantification of total DEGs in adult *Nes^Cre^Csf1^fl/fl^* and *Il34^Lacz/Lacz^* microglia from cerebellum (Cb; left) and forebrain (Fb; middle) and total number of up-regulated intersecting genes from DAM and CSF-1R ligand deficient microglia (right). **(F and G)** Experimental design (F) used to generate data for heat map (G) of select representative DEGs involved in growth, differentiation, metabolism (red), and immune response (purple) pathways induced in WT neonatal cortical and cerebellar microglia stimulated with either 100 ng/ml IL-34 or 20 ng/ml CSF-1 for 24 h. DEGs defined as read cutoff \> 10, P-value \< 0.05 (A and E), and LogFC(TPM) \> 0.25, Benjamini--Hochberg adjusted P-value \< 0.05 (G). Graphs show means ± SEM.](JEM_20182037_Fig2){#fig2}

Using congenic parabiotic mice, we confirmed that cerebellar microglia were maintained locally (Fig. S3 A), independent of adult hematopoiesis, as previously described for whole brain microglia ([@bib1]; [@bib21]). This was confirmed with flow cytometry showing no differences in *Nes^Cre^Csf1^fl/fl^* cerebellar microglia expression of Tmem119, a microglial marker absent on peripherally derived monocytes and macrophages (Fig. S3 B; [@bib6]), therefore excluding that peripherally derived monocytes accounted for the remaining microglia in *Nes^Cre^Csf1^fl/fl^* cerebella. We also confirmed these cells were not replaced by perivascular macrophages, as there were no changes in key genes reported to be specifically up-regulated in these border-associated cells (*Mrc1*, *Cd36*, *Lyve1*, *Slc40a1*, and *Hpgd*; [@bib22]; Fig. S3 C). Reduction of microglia was already observed at embryonic day 13.5 (E13.5) in *Nes^Cre^Csf1^fl/fl^* brain rudiments ([@bib30]; Fig. S3, D and E; and Fig. S5), remained low at E17.5 (Fig. S3 F), and was more prominent in the cerebellum than in the forebrain ([Fig. 3 A](#fig3){ref-type="fig"}). However, macrophages were not affected in the yolk sac, fetal liver, or fetal limbs of *Nes^Cre^Csf1^fl/fl^* mice (Fig. S3, G and H). In contrast, *Il34^LacZ/LacZ^* mice did not exhibit reduced microglia during embryonic development as previously reported ([@bib24]; Fig. S3 I). Cerebellar microglia remained reduced throughout life in *Nes^Cre^Csf1^fl/fl^* mice ([Fig. 3 B](#fig3){ref-type="fig"}). Interestingly, forebrain microglia in *Nes^Cre^Csf1^fl/fl^* mice, while reduced in embryos, recovered by P23 ([Fig. 3 B](#fig3){ref-type="fig"}), suggesting a developmental switch in growth factor demand and an acquired dependence on the *Il34* ligand (Fig. S3, I and J).

![**CSF-1 controls microglia morphology, spatial distribution, and development during embryonic and adult life. (A)** Flow-cytometric quantification of doublet^−^DAPI^−^CD45^+^Ly6G^−^CD11b^lo^F4/80^hi^ microglia from E17.5 *Csf1^fl/fl^* and *Nes^Cre^Csf1^fl/fl^* forebrain (Fb) and cerebella (Cb). *n* = 3--5 mice/group. Data are pooled from two independent experiments. **(B)** Quantification of doublet^−^DAPI^−^CD11b^+^CD45^int^ microglia from P8, P23, P56, and 2-yr-old *Csf1^fl/fl^* and *Nes^Cre^Csf1^fl/fl^* forebrain and cerebellum. *n* = 3--5 mice/group. Data are pooled from at least two independent experiments. **(C)** Representative immunofluorescence stainings of Iba1^+^ microglia in newborn (P0.5) pups, in control, and *Nes^Cre^Csf1^fl/fl^* cerebella. Image representative of *n* ≥ 3 mice/group from two independent litters. Scale bars, 500 μm (upper right), 20 μm (lower middle), and 100 μm (lower right). **(D)** Representative immunofluorescence stainings showing morphological and spatial distribution of Iba1^+^ microglia in P8 *Csf1^fl/fl^* and *Nes^Cre^Csf1^fl/fl^* cerebella. Ki67^+^ cells, proliferating external granule cell layer; ML, molecular layer. Scale bars, 200 µm (left) and 100 µm (right). Image representative of *n* = 3 mice/group of at least three independent experiments. White segmented lines define borders of layers. **(E)** Quantification of Iba1^+^ microglia within P7 *Csf1^fl/fl^* and *Nes^Cre^Csf1^fl/fl^* cerebellar white matter and cortex (left), and percentage of microglia located only in the white matter (right). *n* = 3 mice/group, four sections/mouse, one representative experiment of two independent experiments. **(F and G)** Imaris automated 3D reconstruction (F) and process quantification (G) of Iba1^+^ microglia in P8 *Csf1^fl/fl^* (blue) and *Nes^Cre^Csf1^fl/fl^* (orange) cerebella. Scale bar, 10 µm. *n* = 3 mice/group, *n* = 12--34 cells/genotype. Graphs show mean ± SEM. \*, P ≤ 0.05; \*\*, P ≤ 0.01; \*\*\*\*, P \< 0.0001 using Student's *t* test.](JEM_20182037_Fig3){#fig3}

Imaging of the cerebellum of *Nes^Cre^Csf1^fl/fl^* mice at birth (P0.5; [Fig. 3 C](#fig3){ref-type="fig"}) and at P6--8 ([Fig. 3 D](#fig3){ref-type="fig"}) revealed scarce microglia with a rounded, amoeboid morphology confined to the cerebellar white matter ([Fig. 3 E](#fig3){ref-type="fig"}), with significant alterations in microglial process morphology, including volume, length, and number of branches ([Fig. 3, F and G](#fig3){ref-type="fig"}). Control microglia, however, were ramified and distributed throughout the white matter, the PC layer, the molecular layer, and the developing granule cell layers ([Fig. 3, C--G](#fig3){ref-type="fig"}).

CSF-1--deficient mice have cerebellar alterations and behavioral defects {#s05}
------------------------------------------------------------------------

Magnetic resonance imaging (MRI) of *Nes^Cre^Csf1^fl/fl^* brains revealed increased brain mass, reduced brain size and ventricle volume (Fig. S4, A and B), and increased cerebellar volume (Fig. S4 B), consistent with prior reports in *Csf1^op/op^* and *Csf1r^−/−^* mice ([@bib53]). Strikingly, *Nes^Cre^Csf1^fl/fl^* mice had a significant reduction of PC numbers ([Fig. 4 A](#fig4){ref-type="fig"} and Fig. S4 C), which was also confirmed in CSF-1--deficient *Csf1^op/op^* mice (Fig. S4 D). In contrast to previous reports ([@bib51]; [@bib53]), *Csf1r* was not expressed by calbindin^+^ (calb^+^) PCs (Fig. S4, E and F). We confirmed that *Csf1r* was mainly expressed in microglial cells using TRAP (Fig. S4 G), as well as with RT-PCR (Fig. S4 H). As in mouse brains, human PCs also lacked *CSF1R* expression (Fig. S4 I). PCs form a continuous cellular layer within the cerebellar cortex, and their dendritic trees expand into the cerebellar molecular layer. While the main excitatory inputs of the cerebellar cortex originate from climbing and parallel fibers, the only cerebellar output is from PC axons, and their synaptic plasticity is required for successful motor learning ([@bib54]). Imaging of *Nes^Cre^Csf1^fl/fl^* PCs revealed an increase in aberrant dendrites emerging from PC somas ([Fig. 4 B](#fig4){ref-type="fig"} and Fig. S4, J and K), and overall increased branching assessed by dendrite branching complexity quantification. There was no change in dendritic spine density ([Fig. 4, D and E](#fig4){ref-type="fig"}), but there was decreased mean spine diameter, spine head diameter, and mean spine head volume-to-length ratio ([Fig. 4 E](#fig4){ref-type="fig"}), suggesting a defect in PC neural circuit formation. Climbing fiber elimination is a neurodevelopmental process ensuring that each PC ultimately receives inputs from a single climbing fiber, a process that starts in the first postnatal week ([@bib35]). Developing microglia cluster below the PC layer at P7, and participate in climbing fiber elimination ([@bib52]). At P7, *Nes^Cre^Csf1^fl/fl^*, PC dendrites were shorter, resulting in a thinner molecular cell layer ([Fig. 4, F and G](#fig4){ref-type="fig"}), suggesting an altered and delayed PC maturation. PC soma were devoid of microglia interactions ([Fig. 3, D and E](#fig3){ref-type="fig"}; and [Fig. 4 F](#fig4){ref-type="fig"}) and contained more vesicular glutamate transporter 2 (VGluT2)^+^ climbing fiber puncta ([Fig. 4, H and I](#fig4){ref-type="fig"}), suggesting decreased climbing fiber elimination.

![***Nes^Cre^Csf1^fl/fl^* mice have morphological PC alterations. (A)** Quantification of PC numbers per sagittal section in 6-wk-old *Csf1^fl/fl^* and *Nes^Cre^Csf1^fl/fl^* cerebella, stained with H&E. *n* = 4 mice/group, one or two sections/mouse, pooled from two independent experiments. **(B and C)** Representative whole cell imaging (B) and dendrite branching complexity quantification (C) of biocytin-filled and fluorophore-conjugated--streptavidin-stained PC. Arrows point to aberrant dendrites emanating from *Nes^Cre^Csf1^fl/fl^* PC soma. Scale bars, 20 µm. *n* = 3 mice/genotype, *n* = 7 or 8 cells/group, pooled from three independent patch experiments. Only dendrite branching up to 200 µm radii from PC soma center was quantified, as dendrites beyond this distance may not have been reliably filled with biocytin. **(D)** Representative confocal images of biocytin-labeled PC dendrites and spines from *Csf1^fl/fl^* and *Nes^Cre^Csf1^fl/fl^* cerebella. Scale bars, 2 µm. **(E)** Imaris quantification of PC dendritic spines in *Csf1^fl/fl^* and *Nes^Cre^Csf1^fl/fl^* cerebella. **(D and E)** *n* = 3 mice/genotype, *n =* 3 neurons/mouse, *n =* 5 dendrites/neuron, pooled from three independent patch experiments. **(F and G)** Representative confocal images of calb^+^ PC and Iba1^+^ microglia (F) and quantification of PC and molecular cell layer thickness (G) in P7 *Csf1^fl/fl^* and *Nes^Cre^Csf1^fl/fl^* cerebella. *n* = 3 mice/group, four to six sections/mouse. Scale bar, 100 μm. **(H and I)** Representative confocal images of VgluT2^+^ puncta on calb^+^ PC soma (H) and quantification of VGluT2^+^ puncta per PC soma (I) in P7 *Csf1^fl/fl^* and *Nes^Cre^Csf1^fl/fl^* cerebella. *n* = 3 or 4 mice/group, four to six sections/mouse. Scale bars, 10 μm (right panel) and 5 μm (middle panel). Graphs show means ± SEM. \*, P ≤ 0.05; \*\*, P ≤ 0.01; \*\*\*, P ≤ 0.001; \*\*\*\*, P ≤ 0.0001, using Student's *t* test (A, E, G, and I), and two-way ANOVA (C).](JEM_20182037_Fig4){#fig4}

Electrophysiological analysis of PCs in 6-wk-old mice showed increased spontaneous miniature excitatory postsynaptic currents (mEPSCs), with no differences in amplitude ([Fig. 5, A and B](#fig5){ref-type="fig"}), consistent with excess dendrite branching observed in the remaining PCs in these mice. Strikingly, *Nes^Cre^Csf1^fl/fl^* mice showed mild signs of ataxia (Fig. S4 L), and when tested for motor learning capacities during repeated trials on an accelerating rotarod, 5--7-wk-old *Nes^Cre^Csf1^fl/fl^* mice displayed impairment on the fourth training day ([Fig. 5 C](#fig5){ref-type="fig"}), suggesting a motor learning deficit consistent with cerebellar dysfunction. Besides its well-known role in motor coordination and function, the cerebellum is increasingly appreciated as an important regulator of higher cognitive functions ([@bib73]). We therefore performed two behavioral tests, social preference and social novelty, in *Nes^Cre^Csf1^fl/fl^* mice using the three-chamber sociability paradigm ([Fig. 5 D](#fig5){ref-type="fig"}). Both *Csf1^fl/fl^* and *Nes^Cre^Csf1^fl/fl^* mice showed no defects in the social preference test, both spending significantly more time interacting with the stimulus mouse over the inanimate cup ([Fig. 5 E](#fig5){ref-type="fig"}). However, *Nes^Cre^Csf1^fl/fl^* mice failed to preferentially interact with a novel stimulus mouse ([Fig. 5 F](#fig5){ref-type="fig"}), indicating a deficit in social memory, a behavioral defect commonly found in mouse models of neurodevelopmental and neuropsychiatric disorders, such as autism spectrum disorders (ASDs).

![***Nes^Cre^Csf1^fl/fl^* mice show electrophysiological PC alterations and develop motor and behavioral defects. (A and B)** Representative traces (A) and quantification (B) of PC mEPSC frequencies and amplitudes in *Nes^Cre^Csf1^fl/fl^* PCs compared with controls. *n* = 3 mice/genotype, *n* = 6 cells/mouse. Data are a pool of three independent patch experiments. **(C)** Quantification of the latency for *Csf1^fl/fl^* and *Nes^Cre^Csf1^fl/fl^* mice to fall from accelerating rotating beam. *n* = 12--15 mice/group, pooled from two independent experiments. **(D--F)** Schematic (D) and quantification (E and F) of the three-chamber sociability paradigm used to assess defects in social preference (E) and social novelty (F) in *Csf1^fl/fl^* and *Nes^Cre^Csf1^fl/fl^* mice. stim, stimulus. *n* = 10--12 mice/group, pooled from two independent experiments. Graphs show means ± SEM. ns, not significant; \*, P ≤ 0.05; \*\*, P ≤ 0.01; \*\*\*, P ≤ 0.001, using multiple Student's *t* tests (A) and one-way ANOVA (C and D).](JEM_20182037_Fig5){#fig5}

Discussion {#s06}
==========

Cerebellar microglia display a unique morphological ([@bib3]; [@bib41]) and transcriptional ([@bib23]; [@bib4]) profile, but little is known about their role in cerebellar development, homeostasis, and function. Here, we explored the role of the macrophage growth factor CSF-1 for microglia development and maintenance in the cerebellum, and the consequences of nervous system CSF-1 depletion for cerebellar development and function. We show that despite both signaling through the same receptor, CSF-1R, the distinct expression patterns of IL-34 and CSF-1 shape microglia numbers and phenotypes in the forebrain and cerebellum. Genetic depletion of *Il34* or *Csf1* expression resulted in mutually exclusive reductions of postnatal microglia numbers, with IL-34 as the main forebrain cytokine, and CSF-1 as the main cerebellum cytokine. CSF-1--deficient animals, which lack cerebellar microglia, displayed alterations in cerebellar morphology, PC loss with increased branching complexity, and motor learning and sociability defects.

Microglia form a grid-like pattern throughout the brain where each microglia controls its own territory that is not shared with others ([@bib37]), facilitating a fine-tuned microglia--neuron interaction. Strikingly, *Nes^Cre^Csf1^fl/fl^* microglia were largely confined to central white matter regions of the cerebellum, instead of being evenly distributed throughout the brain, suggesting a migration defect during cerebellar development. The progressive radial distribution of microglia during cerebellar development and growth has been studied in the quail brain ([@bib12]), but the mechanism of distribution of microglia throughout the brain during development is largely unknown. Cerebellar astrocytes express *Csf1* (Fig. S1 A), a known chemotactic factor for macrophages ([@bib9]; [@bib56]). Because cerebellar astrocytes extend their long and ordered cellular processes throughout several cerebellar layers, they might thus serve as guiding structures for developing microglia. Our data, indeed, suggest that microglia may use CSF-1--secreting cells as a scaffold for radial migration into the gray matter, since the absence of neuroectodermal CSF-1 production left remaining microglia stuck in the central white matter of the cerebellum.

Intriguingly, functional pathways induced in postnatal forebrain and cerebellar microglia stimulated with either IL-34 or CSF-1 mirrored the altered biological pathways of microglia from IL-34 or CSF-1--deficient mice, revealing that CSF-1 and IL-34 are among the key drivers of regional microglial transcriptional signatures. Even more interestingly, microglia isolated from mice that underwent maternal immune activation in utero were also shown to up-regulate gene networks involved in embryonic development ([@bib48]), similar to those described here by CSF-1 treatment, suggesting that increased CSF-1 expressed during maternal immune activation could potentially contribute to this transcriptional phenotype.

Due to their important role in brain development and homeostasis, microglia are involved in virtually all pathological conditions affecting the CNS ([@bib29]; [@bib42]). Accordingly, imaging as well as post-mortem studies show that microglia are activated in both multisystem atrophy and bipolar disorder ([@bib76]; [@bib72]; [@bib39]), which affected the microglia donors analyzed here ([Fig. 1, A and B](#fig1){ref-type="fig"}). Nevertheless, we found clear, fundamental, and biologically relevant transcriptional differences between human cerebellar and forebrain microglia, regardless of clinical disease. These differences were preserved in mouse forebrain and cerebellar microglia ([Fig. 1 C](#fig1){ref-type="fig"}), supporting previous studies reporting regional transcriptional differences in mouse microglia phenotypes ([@bib23]; [@bib4]).

We also show that CSF-1--deficient animals, which lack cerebellar microglia, display alterations in cerebellar morphology, PC number and function, and motor learning and sociability defects. Previous studies have shown that microglia serve a key role in proper cerebellar climbing fiber elimination, both shifting the excitatory drive and decreasing the inhibitory drive onto PCs, starting early in cerebellar development and lasting into adulthood ([@bib52]). Indeed, *Nes^Cre^Csf1^fl/fl^* cerebella have increased VGluT2 excitatory inputs onto developing (P7) PC soma compared with controls, suggesting a defect in early-stage climbing fiber elimination ([@bib31]). Moreover, reduced pruning due to microglia depletion in CSF-1--deficient cerebella could be a potential mechanism by which adult *Nes^Cre^Csf1^fl/fl^* PC branching is increased, and thereby also contributing to the increased firing potential (mEPSC) seen in their PCs. Not only can increased excitatory drive result in neuronal, and particularly PC death ([@bib33]; [@bib62]), but altered climbing fiber elimination can also lead to cerebellar motor dysfunction and ataxia ([@bib32]). Lastly, increasing evidence suggests that cerebellar dysfunction may also contribute to a subset of ASD ([@bib18]), a heterogeneous group of disorders, which presents a substantial challenge to diagnosis and treatment. Accordingly, postmortem brain studies of patients with ASD have consistently reported reduced PC counts in the cerebellar cortex ([@bib5]; [@bib18]), and cerebellar injury is linked to increased incidence of ASD ([@bib43]). Moreover, studies in mouse models have shown that genetic disruption of cerebellar PC function can lead to similar social interaction defects as shown in CSF-1--deficient cerebella ([@bib70]).

Previous reports suggested that PCs express *Csf1r* ([@bib51]; [@bib53]). However, we found no *Csf1r* or *CSF1R* expression in mouse and human PCs, respectively, using multiple techniques and different ages, providing evidence for microglial deregulation as the single driver for the neuronal and behavioral perturbations observed in our CSF-1 deficiency model. In addition, *Iba1^Cre^Csf1r^fl/fl^* mice showed similar PC perturbations ([@bib52]), again supporting a microglial role for PC development and regulation. Further studies must be performed to exclude a transient but relevant PC *Csf1r* expression during embryonic or early postnatal development.

The distinct distribution of IL-34 and CSF-1, and the distinct regional microglial transcriptional signatures described here, are conserved in both the mouse and human brain, highlighting the importance of this discrete expression and signaling for microglial biology. Altogether these results reveal the CSF-1--CSF-1R axis as a critical regulator of cerebellar development and integrity and identify the CSF-1--CSF1-R axis as a potential therapeutic target to help restore cerebellar microglial and PC function, and to improve developmental motor and sociability disorders.

Materials and methods {#s07}
=====================

Animals {#s08}
-------

*Nes^Cre^, Cx3cr1^Cre^*, C57BL/6 CD45.2 and CD45.1, ubiquitin-GFP, and R26-stop-EYFP were purchased from the Jackson Laboratory. *Csf1^fl/fl^* mice were provided by Sherry Abboud Werner (University of Texas Health Science Center, San Antonio, TX; [@bib26]). *Il34^Lacz/Lacz^* mice were generated by the European Conditional Mouse Mutagenesis Program (International Knockout Mouse Consortium project ID: 33127; provided by Marco Colonna, Washington University School of Medicine, St. Louis, MO; [@bib75]). *Nes^Cre^Csf1^fl/fl^* and *Nes^Cre^Csf1^fl/fl^Il34^LacZ/LacZ^* mice were generated in house by crossing *Nes^Cre^*, *Csf1*^fl/fl^, and *Il34^Lacz/Lacz^* mouse lines. *Csf1^op/op^* were originally obtained from the Jackson Laboratory on an outbred C57/BL/J C3Heb/FeJ-a/a CD1 background and backcrossed for ≥10 generations onto the FVB/NJ background. *Tg(Aldh1l1-eGFPL10a)JD130*, *Tg(Pcp2-eGFPL10a)DR168*, *Tg(NeuroD1-eGFPL10a)JP241*, *Tg(Drd1-eGFPL10a)CP73*, and *Tg(Drd2-eGFPL10a)CP101* mice were used for astrocyte-, PC-, granule cell--, D1 neuron--, and D2 neuron--TRAP, respectively ([@bib14]; [@bib27]). *Eef1a1^LSL.eGFPL10a/+^* mice, which carry a loxP-flanked STOP cassette (LSL) upstream of the *eGFP-L10a* gene under the control of eukaryotic translation elongation factor 1 α 1, *Eef1a1* (provided by Ana Domingos, University of Oxford, Oxford, UK; [@bib65]), were crossed with *Cx3cr1^CreErt2/+(Litt)^* (provided by Dan Littman, New York University School of Medicine, New York, NY; [@bib55]) to generate a microglia-specific TRAP mouse. Microglia-specific mRNA enrichment was validated ([@bib4]). To activate tamoxifen-inducible Cre (CreErt2 or Cre/Esr1\*), mice were gavaged at 4--6 wk of age with five doses of 100 mg/kg of tamoxifen (T5648; Sigma-Aldrich) in corn oil (C8267; Sigma-Aldrich) with a separation of ≥48 h between doses. For timed embryo studies, male and female mice were bred overnight and vaginal plugs looked for the following morning, with this stage considered E0. Mice were housed at two to five animals per cage with a 12-h light/dark cycle (lights on from 0700 to 1900 h) at constant temperature (23°C) with ad libitum access to food and water. All animal protocols were approved by the Institutional Animal Care and Use Committee at the Icahn School of Medicine at Mount Sinai and were performed in accordance with National Institutes of Health guidelines.

RNAscope in situ hybridization {#s09}
------------------------------

Expression and localization of *Csf1r*, *Csf1*, and *Il34* was assessed using RNAscope in situ hybridization technology (ACD) following the manufacturer's instructions. The multiplexed assay was performed on fixed frozen brain, cut in the sagittal plane at 14-μm thickness. Proprietary probes to *Csf1r*, *Il34*, and *Csf1* were hybridized to their respective target RNA for 2 h at 40°C and their signal amplified for 15--30 min at 40°C. The last amplification step contained the fluorophores used for visualization, Alexa Fluor 488 for *Il34*, Atto550 for *Csf1*, and Atto647 for *Csf1r*. Slides were then counter-stained with DAPI for 2 min, mounted with ProLong Gold (Invitrogen), and cover-slipped. Hybridized brain slices were visualized using confocal microscopy (Zeiss) and NanoZoomer whole-slide imaging software (Hamamatsu).

Single-molecule RNA in situ hybridization with immunofluorescence {#s10}
-----------------------------------------------------------------

6-wk-old WT mice (*n* = 5) were anesthetized with ketamine (120 mg/kg) and xylazine (24 mg/kg) and perfused transcardially with 10 ml PBS followed by 40 ml 10% formalin in PBS. The brains were then removed and fixed in 10% neutral-buffered formalin for another 48 h. Fixed brains were embedded in paraffin, sectioned at 5 µm, mounted on Superfrost Plus slides (Thermo Fisher Scientific), baked in a dry oven for 1 h at 60°C, and stored at room temperature until further processing. In situ hybridization was performed using RNAScope custom-designed probes for *Csf1r* in combination with the RNAScope 2.0 Red kit following the manufacturer's recommendation (Advanced Cell Diagnostics). After completing in situ hybridization before colorimetric reaction, sections were rinsed with ddH~2~O, 0.1× PBS, 0.25× PBS, 0.5× PBS, and 1× PBS, blocked in 2% normal goat serum in PBS for 1 h at room temperature, and incubated with calbindin D-28 antibody (dilution 1:5,000; Swant) in 2% normal goat serum in PBS overnight at 4°C. Calbindin signal was amplified with anti-rabbit horseradish peroxidase--conjugated secondary antibody and Alexa Fluor 488 tyramide from the Tyramide Signal Amplification Kit (Life Technologies) following the manufacturer's instructions, and nuclei were stained with DAPI (0.2 mg/ml). Sections were then rinsed with 1× PBS, 0.5× PBS, 0.25× PBS, 0.1× PBS, and ddH~2~O; subjected to colorimetric reaction; dried 15 min at 60°C; mounted using EcoMount (EM897L; Biocare Medical); and dried overnight. Single-plane tile scans were taken under a LSM780 Confocal Microscope (Zeiss) with 10× objective for quantification and representation. *Csf1r*^+^ calb^+^ PCs were manually counted using Zen 2011 software and represented as dot plots using GraphPad Prism v5.01.

Immunofluorescence staining {#s11}
---------------------------

Mice were transcardially perfused with cold 1× PBS and their brains dissected and put into 4% paraformaldehyde overnight. Following fixation, brains were placed into 30% sucrose for two nights before embedding into optimal cutting temperature compound. 20-μm sections were cut from each brain using a cryostat. Sections were then thawed at room temperature, washed in 1× PBS, and incubated with blocking buffer (1× PBS, 0.5% Triton X-100, 2% BSA, and 5% goat serum) for 1 h at 4°C. The following primary antibodies were used overnight at 4°C: Iba1 (1:500; WAKO), Ki-67 (1:100; eBioscience), CD68 (1:250; Serotec), NeuN (1:100; Abcam), calbindin (1:500; CB-955; Abcam), and VGluT2 (1:1,000; AB2251-I; EMD Millipore). Secondary antibodies (all from eBioscience) conjugated to their respective fluorophores were incubated at 1:200 for 2 h at room temperature. Slides were then counterstained with DAPI and mounted with Prolong Gold (Invitrogen) media. Images were acquired using wide-field and confocal microscopy (Zeiss), and analyzed using Fiji (ImageJ) and Imaris (Bitplane). Manual quantifications were performed by an observer blinded to genotypes.

Cell suspension preparation and microglia isolation {#s12}
---------------------------------------------------

Perinatal and adult brains, yolk sac, embryonic limbs, and fetal livers were dissected from mice at specified ages, as previously described ([@bib24]; [@bib40]; [@bib30]). Brains of P21 and older were perfused with ice-cold PBS before tissue isolation, apart from brains used for microglia sorting and subsequent ultra-low input (ULI) RNA sequencing (RNA-seq), according to the Immgen standardized protocol listed on immgen.org. For the perinatal brain, yolk sac, and limbs, the tissue was enzymatically digested with 0.4 mg/μl collagenase IV (C5138; Sigma-Aldrich) for 10--20 min at 37°C, followed by mechanical trituration with an 18-G blunt-tipped syringe and filtration through a 70-μm filter. Adult brain was digested with 0.4 mg/μl collagenase IV for 30 min. Fetal liver tissue was only mechanically triturated to obtain a homogeneous cell suspension. Cell pellets from all adult brain were further processed by centrifugation in 5 ml of 40% Percoll (Sigma-Aldrich), at 2,300 rpm for 25 min with no brake. Myelin was aspirated, and the cell pellet was washed twice with FACS buffer (PBS without Ca^2+^ and Mg^2+^ supplemented with 2% heat-inactivated FBS and 5 mM EDTA) before staining. For parabionts, brain regions specified were dissected, minced, and digested in RPMI supplemented with 10% FCS, 0.2 mg/ml collagenase IV, and 0.06 mg/ml DNaseI, for 1 h at 37°C. Cells were pelleted at 1,350 rpm for 5 min, and resuspended with 7 ml of 30% Percoll. The cell suspension was spun at 3,000 rpm for 10 min with no brake and washed twice with FACS buffer before staining.

Flow cytometry and microglia sorting {#s13}
------------------------------------

Following single-cell suspension preparation, cells were pelleted and subsequently stained with fluorophore-conjugated antibodies against CD11b (clone M1/70), CD45 (clone 30-F11), CD45.1 (clone A20), CD45.2 (clone 104), CX3CR1 (clone SA011F11; BioLegend), F4/80 (clone BM8; BioLegend), Ly6C (clone HK1.4), Ly6G (clone 1A8; BioLegend), Gr-1 (clone RB6-8C5), CD115 (clone AFS98), MHC II (clone M5/114.15.2), CD11c (clone N418), CD64 (clone X54-5/7.1; BioLegend), CD86 (clone GL1; BioLegend), Tmem119 (clone 106--6; Abcam), and either DAPI or propium iodide viability dyes (all from eBioscience if not indicated otherwise). Flow cytometry was performed using a Fortessa analyzer (BD Biosciences), and FACS was performed using a FACS Aria II (BD Biosciences) or LSRII (BD Biosciences). The gating strategies used for flow cytometry analysis of embryonic tissues are adapted from [@bib30] and shown in Fig. S5. Resident microglia were sorted as doublet^−^DAPI^−^CD11b^+^CD45^int^ (Fig. S2 B). Flow cytometry data analysis was performed using FlowJo (TreeStar) software. For ULI RNA-seq, microglia were double-sorted to reach a purity of \>98%, and 1,000 cells were sequenced.

Parabiosis {#s14}
----------

Parabiotic mice were generated by surgically linking age- and size-matched congenic CD45.2 (C57BL/6) and CD45.1 (C57BL/6) mice as previously described ([@bib20]).

Primary neonatal microglia culture {#s15}
----------------------------------

Preparation of primary neonatal microglia culture was adapted from ([@bib7]). The cerebellum and cortex from 10--20 newborn pups (P2--3) were dissected and mechanically triturated with a P1,000 (200--1,000 μl) pipette in ice-cold 1× HBSS. Following incubation for 15 min at 37°C in 0.25% trypsin/EDTA (Thermo Fisher Scientific), cells were spun down and washed twice in 1× HBSS. Cells were then resuspended in complete medium (DMEM, 10% FBS, 100 U/ml penicillin, and 100 mg/ml streptomycin) and split evenly into three poly-D-lysine (Sigma-Aldrich)--coated T-75 flasks. Half of the medium was changed 3 d later, and subsequently every other day. Between days 10--14 after plating into flasks, the media were removed from each flask, and the cells were dissociated by incubating in Accutase (Thermo Fisher Scientific) for 10 min at 37°C. Cells were then pelleted, washed, and stained on ice for 30 min before FACS. Sorted DAPI^−^CD11b^+^CD45^int^ microglia from the mixed culture were seeded at density of 2 × 10^5^ cells onto poly-D-lysine--coated 12-well plates in complete medium containing either 100 ng/ml IL-34 or 20 ng/ml CSF-1 for 24 h.

Human samples {#s16}
-------------

Brain tissue was provided by the Netherlands Brain Bank (NBB). Informed consent for research purposes was obtained for brain autopsy and the usage of tissue and clinical information. The procedures of the NBB are in accordance with all national laws and regulations and respect human rights (the right to life, liberty, and security of person). The NBB adheres to the standards for quality, safety, and ethics for obtaining and handling of human tissue, as described in BrainNet Europe's Code of Conduct for brain banking. The NBB's procedures have been approved by the ethics committee of the VU University Medical Center (Amsterdam, Netherlands), where all autopsies take place. For this study, brain tissues were collected from two female donors with bipolar disorder (aged 45 yr) and multisystem atrophy (aged 60 yr) and processed according to standardized protocols for next-generation sequencing of primary microglia.

Next-generation sequencing {#s17}
--------------------------

### Human microglia {#s18}

Primary microglia obtained from the NBB were isolated as described before ([@bib49]) with minor modifications. In short, 2--10 g of superior temporal gyrus and cerebellum was collected from two female donors within 8 h after death and stored in Hibernate medium on ice, and the isolation procedure was started within 2 to 24 h after autopsy. A single-cell suspension was generated by dissociating the tissue mechanically through a metal sieve, followed by an enzymatic digestion using collagenase Type I (3,700 U/ml; Worthington) and DNaseI (200 µg/ml; Roche). Microglia were further purified using a Percoll gradient and positive selection using CD11b-conjugated magnetic microbeads (Miltenyi Biotec), which resulted in a 99% pure microglia population as analyzed by flow cytometry. Microglia were lysed in RLT buffer (Qiagen), and RNA was extracted according to the protocol provided by the RNeasy Mini Kit (Qiagen). cDNA synthesis and library preparation were performed using the SMART-Seq v4 Ultra Low Input RNA Kit and Low Input Library Prep Kit v2 (Clontech), respectively. Sequencing was performed using the Illumina NextSeq-500 system. Transcript abundances were quantified with the Ensembl GRCh38 cDNA reference using Kallisto version 0.43.0. Transcript abundances were summarized to gene level using tximport. The expression matrix was filtered only for transcripts with \>5 reads per kilobase of transcript per million mapped reads (RPKM) in both replicates of at least one brain region, leaving 9,927 genes. Differential expression statistics between different brain regions were generated using DEseq2. Genes with a Benjamini--Hochberg adjusted P-value \<0.1 were called differentially expressed. Gene ontology (GO) term enrichment was performed using the topGO package in R using genes up-regulated in either brain region as input.

### Primary adult mouse microglia {#s19}

10^3^ forebrain and cerebellar microglia (DAPI^−^CD11b^+^CD45^int^) were FACS-sorted (FACS Aria II; BD) according to the Immgen standardized protocol for ULI RNA-seq ([@bib68]). RNA extraction, library preparation, and sequencing were performed at the Broad Technology Labs Boston using the NextSeq-500 system (Illumina). Differentially expressed genes for ULI RNA-seq were determined as having ≥10 reads and a P-value \<0.05. Differential expression statistics were calculated with the edgeR package in R. Comparison of CSF-1--deficient microglia RNA-seq data to published data of sorted myeloid populations from adult mice (40) were downloaded from the National Center for Biotechnology Information (Gene Expression Omnibus \[GEO\] accession no. [GSE63340](GSE63340)). The dataset was renormalized with the dataset from the present study using the TMM normalization as implemented in the calcNormFactors() function in the edgeR package. Datasets were hierarchically clustered using Spearman correlation distance of the top 1,000 differentially expressed genes (DEGs) among sample types as determined using the ebayes() function in the Limma package. For GO term enrichment analysis, DEGs were input to the Panther Classification System using the statistical enrichment test on the "GO biological process complete" annotation dataset. Gene lists for each GO term were generated in R using the intersection of the DEGs and Bioconductor's Genome wide annotation for Mouse (org.Mm.egGO2ALLEGS). Panther Classification System and Bioconductor's Genome wide annotation for Mouse are both sourced by the Gene Ontology database. Gene set enrichment analysis plots were generated using GSEA software ([@bib66]) using our DEG values for P8 *Csf1^fl/fl^* and *Nes^Cre^Csf1^fl/fl^* cerebellar microglia and pathway gene set lists curated from our GO term analysis, with 1,000 gene permutations. To compare human and mouse microglia, DEseq2 differential expression tables for human and mouse brain region comparisons were filtered for one-to-one orthologues (determined via Ensembl) that were expressed \>5 RPKM in all replicates of at least one brain region in both species, leaving 7,071 genes. To determine conserved brain region expression differences, genes that had an adjusted P-value \< 0.1 and a log~2~FC \> 0.5 in the same direction in both species were selected.

### Cultured neonatal mouse microglia {#s20}

Following 24-h incubation with either IL-34 or CSF-1, the supernatant was removed, and the attached microglia were harvested directly in Qiazol (Qiagen). Total RNA was extracted using the miRNeasy Kit (Qiagen) following the manufacturer's protocol. cDNA synthesis and library preparation were performed using the SMART-Seq v4 Ultra Low Input RNA Kit and Low Input Library Prep Kit v2 (Clontech), respectively. Sequencing was performed using the Illumina NextSeq-500 system. Transcript abundances were quantified with the Ensembl GRCm38 Mouse cDNA and non-coding RNA reference using Kallisto version 0.43.0. Transcript abundances were summarized to gene level using tximport. The expression matrix was filtered only for transcripts with \>2 transcripts per kilobase million (TPM) in all replicates of at least one condition, leaving 10,751 genes. Differentially expressed genes for neonatal microglial cultures were determined using a one-way ANOVA and a Benjamini--Hochberg adjusted P-value threshold \< 0.01. Differential expression statistics between specific conditions were calculated using the Limma package in R ([@bib58]). Hierarchical clustering of genes was done using Pearson correlation distance and average linkage. Principal component analysis for the neonatal cultures was done using Log2(TPM + 1) values for genes determined to be differentially expressed by one-way ANOVA, 675 genes in total. Genes specifically up-regulated for either cytokine were identified by selecting those that had at least a log2FC \> 0.25 and an adjusted P-value \< 0.05 in one condition compared with all of the other three.

TRAP {#s21}
----

6--8-wk-old transgenic Tg(Aldh1l1-eGFPL10a)JD130, Tg(Pcp2-eGFPL10a)DR168, Tg(NeuroD1-eGFPL10a)JP241, Tg(Drd1-eGFPL10a)CP73, Tg(Drd2-eGFPL10a)CP101, and Cx3cr1^CreErt2/+(Litt)^; Eef1a1^LSL.eGFPL10a/+^ mice (*n* = 2--6 per genotype) were euthanized with CO~2~, and brain regions of interest were dissected. Ribosome-associated mRNA from neurons, microglia, or astrocytes was isolated from each region as previously described ([@bib27], [@bib28]) where each sample corresponds to a single mouse. RNA clean-up from TRAP samples and 5% of the unbound fractions from TRAP samples was performed using the RNeasy Mini Kit (Qiagen) following the manufacturer's instructions. RNA integrity was assayed using an RNA Pico chip on a Bioanalyzer 2100 (Agilent), and only samples with RNA integrity number \> 9 were considered for subsequent analysis. Double-stranded cDNA was generated from 1--5 ng of RNA using Nugen Ovation V2 kit (NuGEN) following the manufacturer's instructions. Fragments of 200 bp were obtained by sonicating 500 ng of cDNA per sample using the Covaris-S2 system (duty cycle: 10%, intensity: 5.0, bursts per second: 200, duration: 120 s, mode: frequency sweeping, power: 23 W, temperature: 5.5--6°C; Covaris). Subsequently, these fragments were used to produce libraries for sequencing by the TruSeq DNA Sample kit (Ilumina) following the manufacturer's instructions. The quality of the libraries was assessed by 2200 TapeStation (Agilent). Multiplexed libraries were directly loaded on NextSeq 500 (Ilumina) with High Output single read sequencing for 75 cycles. Raw sequencing data were processed by using Illumina bcl2fastq2 Conversion Software v2.17. Raw sequencing reads were mapped to the mouse genome (mm9) using the TopHat2 package (v2.1.0; [@bib38]). Reads were counted using HTSeq-count (v0.6.0; [@bib2]) against the Ensembl v67 annotation. The read alignment, read counting, and quality assessment using metrics such as total mapping rate and mitochondrial and ribosomal mapping rates were done in parallel using an in-house workflow pipeline called SPEctRA ([@bib57]). Dow plots representing RPKM of indicated genes were made on GraphPad Prism v5.01.

IL-34 ELISA {#s22}
-----------

Brains were isolated, and indicated regions were dissected, flash-frozen in liquid nitrogen, and stored at −80°C until further use. Proteins were extracted by homogenizing the tissue in ice-cold radioimmunoprecipitation assay buffer (Sigma-Aldrich), and lysates were centrifuged at 16,000 ×*g* at 4°C. Supernatants containing 70 µg of total protein were used to determine IL-34 concentration using an IL-34 ELISA kit (BioLegend).

Quantitative RT-PCR (qRT-PCR) {#s23}
-----------------------------

RNA was extracted from FACS-isolated GFP^+^ cells from P6 *Atoh1-GFP* mice ([@bib10]), FACS-isolated CFP^+^ cells from P6 *Nes-CFP* mice ([@bib50]), FACS-isolated TdTomato^+^ cells from P6 *Pcp2^Cre/+^;R26^LSL-TdTomato/+^* mice ([@bib79]; [@bib45]), and 6-wk-old *Csf1^fl/fl^* and *Nes^Cre^Csf1^fl/fl^* mice using a miRNeasy Micro Kit (Qiagen), according to the manufacturer's protocol. cDNA was prepared using the iScript cDNA synthesis kit (Bio-Rad). qRT-PCR was performed using PowerUp Sybr Green Master Mix (Applied Biosystems). Fold-changes in expression were calculated using the ΔΔCt method. The *Gapdh* gene was used to normalize the results. The following primer pairs were used: *Csf1*: F, 5′-CAT​CCA​GGC​AGA​GAC​TGA​CA-3′ and R, 5′-CTT​CGT​GAT​CCT​CCT​TCC​AG-3′ ([@bib26]); *Csf1r*: F, 5′-TGT​CAT​CGA​GCC​TAG​TGG​C-3′ and R, 5′-CGG​GAG​ATT​CAG​GGT​CCA​AG-3′; *Il34*: F, 5′-CTT​TGG​GAA​ACG​AGA​ATT​TGG​AGA-3′ and R, 5′-GCA​ATC​CTG​TAG​TTG​ATG​GGG​AAG-3′; and *Gapdh*: F, 5′-CCA​AGG​TGT​CCG​TCG​TGG​ATC​T-3′ and R, 5′-GTT​GAA​GTC​GCA​GGA​GAC​AAC​C-3′.

Human PC and brain tissue RNA-seq data {#s24}
--------------------------------------

Single-cell RNA-seq data from human PCs were extracted from the Encyclopedia of DNA Elements (ENCODE) database. 6-yr-old patient ENCODE listing was ENCSR900JSG, GEO:[GSE78474](GSE78474). 20-yr-old patient ENCODE listing was ENCSR8882YA, GEO:[GSE78473](GSE78473). *IL34* and *CSF1* RNA-seq data from human forebrain and cerebellar tissue were extracted from the Human Protein Atlas database ([@bib71]) using the Genome Tissue Expression RNA-seq dataset.

Patch-clamp recording {#s25}
---------------------

Animals were decapitated under isofluorane anesthesia. Brains were quickly removed and transferred into ice-cold (0--4°C) artificial cerebrospinal fluid (ACSF) of the following composition (in mM): 210.3 sucrose, 11 glucose, 2.5 KCl, 1 NaH~2~PO~4~, 26.2 NaHCO~3~, 0.5 CaCl~2~, and 4 MgCl~2~. Acute sagittal slices (350 µm) were prepared from the cerebellum of 4-wk-old mutant and control littermates. Slices were allowed to recover for 40 min at room temperature in the same solution, but with reduced sucrose (105.2 mM) and addition of NaCl (109.5 mM). Following recovery, slices were maintained at room temperature in standard ACSF composed of the following (in mM): 119 NaCl, 2.5 KCl, 1 NaH~2~PO~4~, 26.2 NaHCO~3~, 11 glucose, 2 CaCl~2~, and 2 MgCl~2~. Whole-cell patch-clamp recordings ([@bib16]; [@bib70]) were taken using borosilicate glass electrodes (3--5 MΩ), from the soma of visually identified PCs located at the ganglionic layer of the cerebellum, which are clearly visible even under 10× objective. Whole-cell voltage-clamp recordings were obtained with the internal solution containing (in mM): 120 Cs-methanesulfonate, 10 Hepes, 0.5 EGTA, 8 NaCl, 4 Mg-ATP, 1 QX-314, 10 Na-phosphocreatine, and 0.4 Na-GTP. mEPSCs were passively recorded in the presence of tetrodotoxin (1 µM; Abcam) in the standard ACSF (as above). mEPSCs were recorded at −60 mV. Data were low-pass filtered at 10 kHz and acquired at 10 kHz using Multiclamp 700B (Axon Instruments) and pClamp 10 (Molecular Devices). PCs for recording were selected at random. Series and membrane resistance was continuously monitored, and recordings were discarded when these measurements changed by \>20%. Recordings in which series resistance exceeded 25 MΩ were rejected. Detection and analysis of EPSCs were performed using MiniAnalysis (Synaptosoft). Series resistance was monitored and canceled using a bridge circuit, and pipette capacitance was compensated. Voltage signals were low-pass filtered at 10 kHz.

VGluT2 and PC quantification and structural analysis {#s26}
----------------------------------------------------

### PC quantification {#s27}

Male P7, P21, and 6-wk-old *Csf1^fl/fl^* and *Nes^Cre^Csf1^fl/fl^* littermates and 2-wk-old FVB WT and *Csf1^op/op^* mice on FVB background were perfused transcardially with 4% paraformaldehyde, pH 7.4, and brains were incubated overnight in the same. For P7 and P21 *Csf1^fl/fl^* and *Nes^Cre^Csf1^fl/fl^* mice, brains were cut in half sagittally, sectioned at 15 µm, and stained with anti-calbindin, anti-VGluT2 antibody, and DAPI. PCs were counted in the manually determined PC and molecular cell layers using Imaris. VGluT2 puncta on manually outlined PC soma were automatically determined using Imaris Spot Function. For 6-wk-old *Csf1^fl/fl^* and *Nes^Cre^Csf1^fl/fl^* mice, brains were cut in half sagittally and sectioned at 5 µm. Slides were stained with H&E and scanned for digital imaging (Pannoramic 250 Flash III whole-slide scanner, 3DHISTECH). All PCs of all whole cerebellar sections were manually counted by an observer blinded to genotypes. For WT and *Csf1^op/op^* mice, 5-µm-thick paraffin-embedded brain sections were stained with H&E and pictures obtained by a Leica microscope. PCs were quantitated from H&E-stained sections from cerebellar lobes IX--X by manual counting.

### Intracellular labeling of PCs {#s28}

Randomly selected PCs that were being passively recorded were filled with 0.4% biocytin (Tocris) using patch-clamp recording pipettes once the recordings were completed ([@bib34]). Neurons in deeper portions of the PC layer were targeted and filled for 15 min, and then the pipette was slowly withdrawn so that the cell membrane could reseal. Slices (350 mm thick) were then fixed in 4% paraformaldehyde in 0.1 M phosphate buffer for 24 h, rinsed thoroughly in PBS and incubated for 90 min in a PBS solution containing 0.5% Triton X-100, 10% normal goat serum, and streptavidin Alexa Fluor 488 conjugate (1:500; Life Technologies). Slices were then rinsed in PBS, mounted on Superfrost Plus slides (VWR International), air-dried, and coverslipped in Vectashield mounting media (Vector Labs) for the subsequent imaging.

### Dendritic spine imaging and characterization {#s29}

Images were acquired using an Upright LSM 780 Confocal microscope (Carl Zeiss). A nonbiased approach was taken to characterize dendritic spines on secondary dendrites within 200 μm of the soma. To assure sufficient sampling, five dendritic spine segments were taken from each neuron, and three neurons were assessed per animal ([@bib15]). Dendritic segments were imaged using a 100× lens (numerical aperture 1.4; Carl Zeiss) and a zoom of 4.0. Images were taken with a resolution of 300 × 100 pixels, dwell time was 1.58 µm/s, and the line average was set to 8. Pixel size was 0.03 μm in the x-y plane and 0.05 μm in the z plane. To assure consistency of imaging across different confocal sessions and at different depths of the tissue, power was consistently set to 3.0%, and gain was adjusted within the range of 600--800 U to achieve consistent light intensity values within the same set of neurons. Images were de-convolved using a three-dimensional (3D) resolution enhancement with AutoDeblur software (Media Cybernetics; [@bib59], [@bib60]; [@bib11]) and then run through the spot detector in Imaris (Bitplane). PC dendritic spine reconstruction and analysis were performed using Imaris FilamentTracer. Start and end points of dendrites to be segmented were manually selected and traced using the AutoPath method, and automatic thresholds used to determine dendrite diameter and surface rendering. Spines were considered to have a minimum seed point diameter of 0.2 μm and a maximum spine length of 2.0 μm (including branched spines). The seed point threshold was manually decreased to detect the maximum seed points for each dendrite. Automatic thresholds were used for spine diameter rendering. The average values for dendritic spine length, density, diameter, and volume measurements were calculated by the Imaris software and exported from the Statistics tab. All analyses were performed blinded to the group conditions until the analyses were completed.

### Whole-cell imaging and dendrite complexity quantification {#s30}

Images were acquired using an Upright LSM 780 Confocal microscope (Carl Zeiss) using a 63× lens (numerical aperture 1.4; Carl Zeiss) and a zoom of 0.6. Images were taken with a resolution of 1,024 × 1,024 pixels, dwell time was 1.58 µm/s, and the line average was set to 4. Pixel size was 0.22 µm in the x-y plane and 1.00 μm in the z plane. Gain was set to 600--800 U. Dendrite complexity quantification was performed using the Sholl analysis plugin in Fiji (ImageJ).

Behavioral tests {#s31}
----------------

### Ataxia assessment {#s32}

Cerebellar ataxia in *Csf1^fl/fl^* and *Nes^Cre^Csf1^fl/fl^* mice was assessed using a composite score of hind limb clasping, ledge test, gait, and kyphosis, as previously described ([@bib20]).

### Rotarod {#s33}

Motor effects in *Il34^LacZ/LacZ^* and *Nes^Cre^Csf1^fl/fl^* animals, and their respective littermate controls, were tested using the accelerating rotarod paradigm ([@bib8]), with additional video recording. Mice were placed on a motorized beam that was accelerated from 4--40 rpm. The latency of the mice to fall was recorded. If an animal clung to the rod and completed a full passive rotation, the timer was stopped for the animal and the time was noted. Prior to the final recorded rotarod session on day 4, with three trials at 5-min intervals each, animals were habituated to the paradigm during three training days with three trials of 5 min each. Differences between groups were statistically evaluated by Student's *t* tests.

### Sociability assessments {#s34}

Sociability deficits were assessed in 6--8-wk-old male *Nes*^Cre^*Csf1*^fl/fl^ mice and their littermate controls. The premise for these behavioral tests lies in the preference of mice spending time around (1) other mice over inanimate objects and (2) novel over familiar subjects ([@bib19]; [@bib17]). To begin, test mice were habituated to an empty three-chambered Plexiglass box for 10 min. Mice were then restricted to the middle chamber by dividers, while a novel inanimate object and a novel stimulus mouse were placed under wire cups in either of the two flanking chambers (social preference). The dividers were then removed and the test mouse was allowed to freely explore the entire box for 10 min. Following this, test mice were again restricted to the middle chamber, while the inanimate object was replaced with a second novel stimulus mouse (social novelty). Test mice were again released from the middle chamber and allowed to explore for 10 min the chambers with the familiar and new stimulus mice. The behavior sessions were recorded using EthoVision (Noldus), and the time each test mouse spent near and/or sniffing the object or stimulus mice was manually recorded. Stimulus mice were age- and sex-matched for these assessments.

MRI {#s35}
---

All imaging was performed at the Translational and Molecular Imaging Institute at Mount Sinai Hospital on a Bruker Biospec 70/30 7Tesla scanner with a B-GA12S gradient insert (gradient strength 440 mT/m and slew rate 3,444 T/m/s). A Bruker four-channel mice brain phased array was used for all data acquisition in conjunction with a Bruker volume transmit 86-mm coil. All mice were imaged under isoflurane anesthesia (3% induction and 1.5% maintenance). All mice were imaged on a heated bed, and respiration was monitored continuously. The following protocols were used. After a three-plane localizer, a diffusion tensor imaging protocol was acquired with a Pulsed Gradient Spin Echo echo-planar imaging sequence with the following parameters: repetition time = 5,500 ms, echo time = 22.672 ms, four segments, 30 gradient directions with b-value = 1,000 s/mm^2^ and 5 B0s, field-of-view = 25 mm, matrix = 128 × 128, slice thickness = 0.5 mm, skip = 0, three averages, and total acquisition time = 38 min. A T2 anatomical scan was obtained with a 3D Rapid Acquisition with Relaxation Enhancement sequence with a Rapid Acquisition with Relaxation Enhancement factor of 8, repetition time = 2,500 ms, effective pulse duration = 62.5 ms, field-of-view = 25.6 mm × 25.6 mm, slice thickness = 0.4 mm, skip = 0, 18 slices, matrix size 256 × 256, 30 averages, and total acquisition time = 31 min. Scans were transferred to offline workstation for processing. In-house software TMII-ROI developed under MATLAB (R2015b; 2000; MathWorks) was used to analyze volume.

Statistical analysis {#s36}
--------------------

For all graphical analyses, mean values, SEM values, Student's *t* tests (two-tailed, unpaired), and one-way ANOVAs were calculated using Prism 7 (GraphPad).

Data and material availability {#s37}
------------------------------

All data are available in the main text or the supplementary materials. RNA-seq and ULI RNA-seq data are deposited in GEO under accession nos. [GSE133357](GSE133357){#dblnk3b18890c-d44b-ec68-eb72-52c3d3a846e0} (human microglia), [GSE133360](GSE133360){#dblnkad2ec2a9-f64a-5b19-64b9-6486549b5b91} (neonatal stimulation microglia), and [GSE133362](GSE133362){#dblnkdaf97659-28d8-4509-fc4a-99234cf36ba}.

Online supplemental material {#s38}
----------------------------

Fig. S1 shows distinct expression patterns of CSF-1 and IL-34 mRNA in mice and humans. Fig. S2 shows *Nes^Cre^Csf1^fl/fl^* microglia profile clusters with published microglia profile and distinct clustering of CSF-1-- or IL-34--stimulated forebrain and cerebellar neonatal microglia. Fig. S3 shows characterization of cerebellar microglia and embryonic macrophages in control and CSF-1--deficient mice. Fig. S4 shows morphological and behavioral alterations in CSF-1--deficient mice. Fig. S5 shows gating strategies for flow cytometry analysis of embryonic tissues in CSF-1--deficient mice. Table S1 shows GO term pathways for RNA-seq expression data of purified human cerebellar and forebrain microglia. Table S2 shows GO term pathways for RNA-seq expression data of sorted P8 and adult Csf1^fl/fl^ and Nes^Cre^Csf1^fl/fl^, and adult Il34^wt/wt^ and Il34^LacZ/LacZ^ cerebellar and forebrain microglia. Table S3 shows GO term pathways for RNA-seq expression data of cultured and sorted primary neonatal cerebellar and forebrain microglia stimulated with CSF-1 or IL-34.
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###### Tables S1-S3 (Excel)
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